VRT.AX - Virtus Health Limited

ASX - ASX Delayed Price. Currency in AUD

Virtus Health Limited

176 Pacific Highway
Level 3
Greenwich, NSW 2065
61 2 9425 1722

IndustryMedical Care
Full Time Employees1,300

Key Executives

NameTitlePayExercisedYear Born
Ms. Susan ChannonCEO, MD & Director637.45kN/A1957
Mr. Glenn PowersCFO & Company Sec.526.87kN/A1960
Mr. Steve ZappiaMD of Queensland & MD of Virtus Health Diagnostics313.97kN/A1959
Ms. Nadia StankovicManaging Director of New South Wales252.87kN/AN/A
Ms. Jade PhelanManaging Director of Victoria324.68kN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Virtus Health Limited provides various healthcare services in New South Wales, Queensland, Victoria, Tasmania, Denmark, the United Kingdom, Ireland, and Singapore. It provides fertility care and related specialized diagnostics, as well as day hospital services. The company offers in-vitro fertilization (IVF) services, including ovulation induction, intrauterine insemination, introcytoplasmic injection, GIFT, blastocyst culture, frozen embryo transfer, egg and semen freezing and storage, testicular biopsy, and support and counseling services, as well as donor egg, embryo, and sperm services. It also provides endocrinology, andrology, preimplantation genetic, and cytogenetic diagnostic services; and gynecological and obstetric ultrasound scanning and procedures. In addition, the company offers day hospital procedures, such as IVF, endoscopy, gynaecology, urology, dental, ophthalmic, cosmetic surgery, and plastic surgery. As of August 21, 2018, it operated through a network of 126 fertility specialists. The company was founded in 2008 and is headquartered in Greenwich, Australia.

Corporate Governance

Virtus Health Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.